Oxidative stress and inflammation in hemodialysis patients

被引:168
作者
Spittle, MA
Hoenich, NA
Handelman, GJ
Adhikarla, R
Homel, P
Levin, NW
机构
[1] Renal Res Inst, New York, NY 10128 USA
[2] Beth Israel Deaconess Med Ctr, Div Nephrol & Hypertens, Boston, MA USA
[3] Beth Israel Deaconess Med Ctr, Dept Biostat, Boston, MA USA
[4] Univ Massachusetts, Dept Hlth & Clin Sci, Lowell, MA USA
关键词
C-reactive protein (CRP); F2-isoprostane; inflammation; oxidative stress;
D O I
10.1053/ajkd.2001.29280
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Dialysis is associated with an increased generation of oxidants, which play an important part in the development of endothelial dysfunction and atherogenesis. Markers of oxidative stress include F2-isoprostanes and ethane. Measurements in dialysis patients before dialysis showed higher levels of esterified plasma F2-isoprostanes (1.62 +/- 0.73 ng/mL) than in control subjects (0.27 +/- 0.10 ng/mL) (P < 0.001). Furthermore, levels also correlated with high plasma C-reactive protein (CRP) levels (r = .48, P = 0.015). Breath ethane levels for dialysis patients (N = 19) were 6.32 +/- 3.16 pmol/kg-min, in contrast to 3.08 +/- 1.50 pmol/kg-min in control subjects (N = 11, P < 0.005). Analysis to investigate the relationship between CRP levels and outcome indicated that there was a significant difference in mortality rate over a 3-year period between patients with low and high CRP values (P < 0.001). Patients with high CRP (> 16.8 mg/L) levels were more than twice as likely to die as patients with low CRP levels (relative risk [RR] = 2.16; 95% confidence interval [CI], 1.50-3.09). CRP values were a significant predictor of mortality even after controlling for diabetes, albumin, ferritin, and age at commencement of dialysis. The FIR for CRP after adjustment was 1.58 (95% Cl, 1.06-2.34, P = 0.024). There were no significant interactions between CRP and other predictors of mortality, indicating that high CRP levels have an additive effect on the mortality risk. These findings show that hemodialysis patients are exposed to both oxidative stress and inflammation. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:1408 / 1413
页数:6
相关论文
共 25 条
[1]   End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? [J].
Arici, M ;
Walls, J .
KIDNEY INTERNATIONAL, 2001, 59 (02) :407-414
[2]  
BABIOR BM, 1992, ADV ENZYMOL RAMB, V65, P49
[3]  
Bohm V, 1997, INT J VITAM NUTR RES, V67, P262
[4]   Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure [J].
CeballosPicot, I ;
WitkoSarsat, V ;
MeradBoudia, M ;
Nguyen, AT ;
Thevenin, M ;
Jaudon, MC ;
Zingraff, J ;
Verger, C ;
Jungers, P ;
DescampsLatscha, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (06) :845-853
[5]   C-REACTIVE PROTEIN INDUCES HUMAN PERIPHERAL-BLOOD MONOCYTES TO SYNTHESIZE TISSUE FACTOR [J].
CERMAK, J ;
KEY, NS ;
BACH, RR ;
BALLA, J ;
JACOB, HS ;
VERCELLOTTI, GM .
BLOOD, 1993, 82 (02) :513-520
[6]   C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors [J].
Cook, DG ;
Mendall, MA ;
Whincup, PH ;
Carey, IM ;
Ballam, L ;
Morris, JE ;
Miller, GJ ;
Strachan, DP .
ATHEROSCLEROSIS, 2000, 149 (01) :139-150
[7]   Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly [J].
DeLeo, FR ;
Renee, J ;
McCormick, S ;
Nakamura, M ;
Apicella, M ;
Weiss, JP ;
Nauseef, WM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :455-463
[8]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[9]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[10]   Prospective study of fibrinolytic factors and incident coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Aleksik, N ;
Park, E ;
Salomaa, V ;
Juneja, H ;
Wu, KK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :611-617